[IMRX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[IMRX] Immuneering Corporation
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 8,590.32%
YoY- 8,352.11%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 0 0 184 748 483 -
PBT -14,308 -13,604 -12,897 -6,230 -3,201 45.36%
Tax -0 -1,075,403 -29 0 0 -
NP -14,308 1,061,799 -12,867 -6,230 -3,201 45.36%
Tax Rate - - - - - -
Total Cost 14,308 -1,061,799 13,051 6,978 3,684 40.35%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 0.00 0.00 -7,004.48 -832.62 -662.61 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.49 40.16 -0.49 -0.46 -0.24 19.52%
EPS Diluted -0.49 40.16 -0.49 -0.46 -0.24 19.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.